Targeting VEGFR2 located on endothelial cells by the cRGD-NP is likely to be very effective because of its ready accessibility, whereas targeting secreted VEGF from both tumor and endothelial cells may be less effective, due to reduced penetration of the tumor by the NP. Here, KDR is linked to neoplasm.